Skip to content

Abdominal aortic aneurysm screening by ultrasonography in primary care

Abdominal aortic aneurysm screening by ultrasonography in primary care: a community screening trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10945166
Enrollment
3348
Registered
2015-03-30
Start date
2015-01-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal aortic aneurysm (AAA) Circulatory System Abdominal aortic aneurysm, without mention of rupture

Interventions

Intervention cohort: all men aged 65 to 74, attended by each of family physician (FP) researchers. Recruitment: Each FP researcher (clinical group) provides a list of patients in the age and sex gro

Sponsors

EOXI Vigo
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: The setting will be the Integrated Management Area of Vigo, which has 583,124 habitants, 23 PC departments and 42 health centres. 21 family doctors (FD) belonging to 14 PC departments in the Vigo area, trained in abdominal ultrasonography and with ultrasound equipment at their health centre, will form the research team’s clinical group. The availability of ultrasound equipment in the centres is part of the portfolio of primary care services of the Vigo area (equipment that is currently available in 11 of the 23 PC departments) and was selected based on the specific training in ultrasonography of any of the family doctors of this centre and their availability to undertake this activity for the whole team. Intervention cohort: 1. Men aged 65 to 74 years The participating patients will sign the informed consent to participate in the study. Patients who choose not to participate or who do not sign the informed consent will be considered losses. The exclusion criteria refer exclusively to age and sex, bedridden/immobilised patients or those with a previously diagnosed aneurysm. 2. The control cohort will consist of patients of the same sex and age belonging to the remaining quotas of the Vigo area. The patients’ data will be extracted anonymously from the administrative databases of SERGAS and therefore do not require informed consent.

Exclusion criteria

Exclusion criteria: 1. Women 2. 74 3. Terminally ill 4. Immobilized 5. Previous AAA diagnosed or repaired.

Design outcomes

Primary

MeasureTime frame
At 31/12/2020, the impact of early diagnosis in reducing overall mortality, cardiovascular mortality and incidental AAA will be evaluated. To this end, information will be requested relative to the intervention and control cohorts from the Death Registry and at the Galician Health Service: Deaths (by all causes and by cardiovascular causes) and patients detected by incidental hospital diagnosis (hospitalisation and/or emergency surgery for AAA). The specific mortality due to AAA will not be considered due to its low sensitivity.

Secondary

MeasureTime frame
1. Cardiovascular mortality 2. Surgery for AAA (type of surgery, scheduled/emergency) 3. Type of discharge from hospital

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026